文献速递MDS 与骨髓增殖性肿瘤贫血与红细胞疾病

吸烟与血细胞及骨髓增殖性肿瘤的荟萃分析与孟德尔随机化研究

Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people.
PubMed 文献 · Br J Haematol · 2019-12-25

结果显示吸烟与白细胞计数及红细胞指数(MCH、MCV、RDW)升高相关,当前吸烟者和既往吸烟者MPN风险均增加。

要点

  • CHRNA3变异与吸烟量相关,遗传预测的吸烟与白细胞、中性粒细胞等升高有关。

核心结论

  • 吸烟在观察性和遗传学上均与白细胞计数及红细胞指数(MCH、MCV、RDW)升高相关。
  • 观察性分析显示当前吸烟者和既往吸烟者较非吸烟者MPN风险增加。

研究设计与样本

  • UK Biobank中利用CHRNA3(rs1051730[A])进行孟德尔随机化分析。

关键数值与推荐

  • 吸烟与白细胞、血细胞比容、血红蛋白、MCH、MCV升高相关,与红细胞及血小板无显著关联。
  • CHRNA3每等位基因与当前吸烟者每日吸烟量相关,且与白细胞、中性粒细胞、MCH、RDW、MCV升高相关。
  • MPN风险随吸烟状态和吸烟量增加而升高,重度吸烟者OR最高。

临床怎么用

  • 吸烟者血细胞计数升高(尤其白细胞、MCV、MCH)时应考虑吸烟影响。
  • MPN风险评估中应纳入吸烟史,尤其重度吸烟者风险更高。
  • 遗传学证据支持吸烟对血细胞指标和MPN风险的潜在因果作用。

局限性

  • 分析呈现高异质性(部分指标),但发表偏倚低。
  • 孟德尔随机化仅针对CHRNA3变异,可能未覆盖吸烟全部遗传效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Meta-analyses and Mendelian randomization (MR) may clarify the associations of smoking, blood cells and myeloproliferative neoplasms (MPN). We investigated the association of smoking with blood cells in the Danish General Suburban Population Study (GESUS, n = 11 083), by meta-analyses (including GESUS) of 92 studies (n = 531 741) and MR of smoking variant CHRNA3 (rs1051730[A]) in UK Biobank, and with MPN in a meta-analysis of six studies (n (total/cases):1 425 529/2187), totalling 2 307 745 participants. In the meta-analysis the random-effects standardized mean difference (SMD) in current smokers versus non-smokers was 0·82 (0·75-0·89, P = 2·0 * 10-108 ) for leukocytes, 0·09 (-0·02 to 0·21, P = 0·12) for erythrocytes, 0·53 (0·42-0·64, P = 8·0 * 10-22 ) for haematocrit, 0·42 (0·34-0·51, P = 7·1 * 10-21 ) for haemoglobin, 0·19 (0·08-0·31, P = 1·2 * 10-3 ) for mean corpuscular haemoglobin (MCH), 0·29 (0·19-0·39, P = 1·6 * 10-8 ) for mean corpuscular volume (MCV), and 0·04 (-0·04 to 0·13, P = 0·34) for platelets with trends for ever/ex-/current smokers, light/heavy smokers and female/male smokers. Analyses presented high heterogeneity but low publication bias. Per allele in CHRNA3, cigarettes per day in current smokers was associated with increased blood cell counts (leukocytes, neutrophils), MCH, red cell distribution width (RDW) and MCV. The pooled fixed-effects odds ratio for MPN was 1·44 [95% confidence interval (CI): 1·33-1·56; P = 1·8 * 10-19 ; I2 = 0%] in current smokers, 1·29 (1·15-1·44; P = 8·0 * 10-6 ; I2 = 0%) in ex-smokers, 1·49 (1·26-1·77; P = 4·4 * 10-6 ; I2 = 0%) in light smokers and 2·04 (1·74-2·39, P = 2·3 * 10-18 ; I2 = 51%) in heavy smokers compared with non-smokers. Smoking is observationally and genetically associated with increased leukocyte counts and red blood cell indices (MCH, MCV, RDW) and observationally with risk of MPN in current and ex-smokers versus non/never-smokers.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Jayasuriya NA, Kjaergaard AD, Pedersen KM, et al. Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people. Br J Haematol. 2019. PMID: 31875952. doi:10.1111/bjh.16321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。